Dandenong Neurology

Call Us: (03) 9791 1599

Location: 136 David Street Dandenong, VIC 3175

Research

bg
Dandenong Neurology and Specialists Group regularly recruits members of the community to participate in research and clinical trials. We are always looking for volunteers (both healthy and Parkinson’s patients). You can make a difference by assisting with the research of new methods and interventions to improve our understanding of various disorders. Most of our research projects are in collaboration with RMIT or Monash University where A/Prof S Raghav holds adjunct positions.

Ongoing Research projects:

We are looking for volunteers to participate in following research projects. Please don’t hesitate to contact us if you have any queries. We can post you PICF (Patient Information & Consent Form) to go through these projects in detail.

  • Analysis of handwriting and voice in Parkinson’s disease. 2015- ongoing
  • Analysis of Gait in Parkinson’s disease. 2015- ongoing
  • Using a non-invasive novel device to differentiate bradykinesia, tremor and dystonia in different movement disorders. 2018 – Ongoing
  • Automated Facial Expression for Parkinson Disease. 2023 – ongoing
  • A comprehensive study for the diagnosis of Parkinson’s disease ; observational-based clinical diagnosis by specialist clinicians versus computerised assessment of hand writing, voice phonemes and features of the eye gaze. 2023-ongoing.
  • A comparative study fo the diagnosis of Parkinson’s disease ; observational-based clinical diagnosis by specialist clinicians versus computerised assessment of hand writing, voice phonemes and features of eye gaze.

Research Studies Completed:

  • Duodopa in Patients with Advanced Parkinson´s Disease (PD) – a Global Observational Study Evaluating Long-Term Effectiveness (DUOGLOBE Study]. 2016-2018
  • An international observational prospective Study on long-term response to Botulinum toxin type A (BoNT-A) injections in subjects suffering from idiopathic cervical dystonia (CD) – pharmaco-economic impact. ( April 2013- 2017)
  • A phase III, randomized, double blind and open label study comparing Dysport and Dysport RU to placebo and assessing the short and long term efficacy and safety. (Jan 2012-May 2013)
  • Laryngeal function in early Parkinson’s Disease and tremor- ( Sept 2011- Feb 2013)
  • Botulinum toxin to treat Vocal cord dysfunction in Bronchial Asthma. (Aug 2011-Dec 2012)
  • Efficacy of Botulinum toxin and repetitive Transcranial magnetic stimulation in treating Cervical Dystonia: Double blind placebo controlled trial (Feb 2010-June 2011)
  • Automated assessment of dyskinesia in Parkinson’s Disease (2010-2011)
  • Comparison of Parkinson-related quality of life and cost effectiveness of a comprehensive service delivery model compared to usual care for the management of people with Parkinson’s disease. 2011- 2014
  • Multinational Multicentre QUEST AP Stalevo Study. (2005-2006)
  • Clinical trial of Levetiracetam for Dyskinesia in Parkinson’s Disease. (2005-2009)
  • Step variability leading up to, and during planned stop in Parkinson’s Gait. (2005-2006)
  • Clobazam as first line therapy in newly diagnosed epilepsy. (2000)
  • Clinical & Magnetic Resonance evaluation of patients with single calcified CT lesions with seizure. (1999-2001)